Peer Reviewed Publications by Faculty Members for
2002, 2003, 2004, 2005 and 2006

2006

1. A. Haverich, S. K. Shernan, J. H. Levy, J. C. Chen, M. Carrier, K. M. Taylor, Werf F. Van de, M. F. Newman, P. X. Adams, T. G. Todaro, Laan M. van der, and E. D. Verrier. Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients. Ann.Thorac.Surg. 82 (2):486-492, 2006.



2. J. H. Levy, G. J. Despotis, and E. Spitznagel. Should aprotinin continue to be used during cardiac surgery? Nat.Clin.Pract.Cardiovasc.Med. 3 (7):360-361, 2006.



3. K. A. Tanaka, F. Szlam, and J. H. Levy. The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generation. Br.J.Haematol. 134 (1):77-82, 2006.



4. J. H. Levy, A. Fingerhut, T. Brott, I. H. Langbakke, E. Erhardtsen, and R. J. Porte. Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion 46 (6):919-933, 2006.



5. J. H. Levy, J. G. Ramsay, and R. A. Guyton. Aprotinin in cardiac surgery. N.Engl.J.Med. 354 (18):1953-1957, 2006.



6. J. H. Levy. Aprotinin versus tranexamic acid: the controversy continues. Transfusion 46 (3):319-320, 2006.



7. M. Carrier, P. Menasche, J. H. Levy, M. F. Newman, K. M. Taylor, A. Haverich, J. C. Chen, S. K. Shernan, Werf F. Van de, Laan M. van der, T. G. Todaro, P. X. Adams, and E. D. Verrier. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery. J.Thorac.Cardiovasc.Surg. 131 (2):352-356, 2006.



8. M. Kikura, J. H. Levy, K. A. Tanaka, and J. G. Ramsay. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery. J.Am.Coll.Surg. 202 (2):216-222, 2006.



9. J. H. Levy. Massive transfusion coagulopathy. Semin.Hematol. 43 (1 Suppl 1):S59-S63, 2006.



10. F. L. Muller, W. Song, Y. Liu, A. Chaudhuri, S. Pieke-Dahl, R. Strong, T. T. Huang, C. J. Epstein, L. J. Roberts, M. Csete, J. A. Faulkner, and Remmen H. Van. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic.Biol.Med. 40 (11):1993-2004, 2006.



11. K. A. Tanaka, J. A. Fernandez, U. M. Marzec, A. B. Kelly, M. Mohri, J. H. Griffin, S. R. Hanson, and A. Gruber. Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates. Br.J.Haematol. 132 (2):197-203, 2006.



12. P. M. Bokesch, G. A. Izykenova, J. B. Justice, K. A. Easley, and S. A. Dambinova. NMDA receptor antibodies predict adverse neurological outcome after cardiac surgery in high-risk patients. Stroke 37 (6):1432-1436, 2006.



13. R. S. Harris, O. Lazar, J. W. Johansen, and P. S. Sebel. Interaction of propofol and sevoflurane on loss of consciousness and movement to skin incision during general anesthesia. Anesthesiology 104 (6):1170-1175, 2006.



14. L. E. Sebel, J. E. Richardson, S. P. Singh, S. V. Bell, and A. Jenkins. Additive effects of sevoflurane and propofol on gamma-aminobutyric acid receptor function. Anesthesiology 104 (6):1176-1183, 2006.



15. R. M. Sniecinski, G. C. Sund, and J. G. Ramsay. An unusual case of endocarditis. Anesth.Analg. 103 (2):307-308, 2006.



16. K. W. Mahaffey, Werf F. Van de, S. K. Shernan, C. B. Granger, E. D. Verrier, T. G. Filloon, T. G. Todaro, P. X. Adams, J. H. Levy, V. Hasselblad, and P. W. Armstrong. Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: A systematic overview. Am.Heart J. 152 (2):291-296, 2006.



17. J. H. Levy. Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery-Yes. J.Thromb.Haemost., 2006.



18. D. D. Denson, J. Li, and D. C. Eaton. Co-localization of the alpha-subunit of BK-channels and c-PLA2 in GH3 cells. Biochem.Biophys.Res.Commun. 350 (1):39-49, 2006.



19. D. Green and P. S. Sebel. Anaesthesia practitioners in the UK: the high road, not yet taken. Eur.J.Anaesthesiol. 23 (11):899-901, 2006.



20. J. W. Johansen. Update on bispectral index monitoring. Best.Pract.Res.Clin.Anaesthesiol. 20 (1):81-99, 2006.



21. C. Kerssens and P. S. Sebel. To BIS or not to BIS? That is the question. Anesth.Analg. 102 (2):380-382, 2006.



22. S. Lee, H. S. Shin, P. K. Shireman, A. Vasilaki, Remmen H. Van, and M. E. Csete. Glutathione-peroxidase-1 null muscle progenitor cells are globally defective. Free Radic.Biol.Med. 41 (7):1174-1184, 2006.



23. J. H. Levy and P. S. O'Donnell. The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema. Expert.Opin.Investig.Drugs 15 (9):1077-1090, 2006.



24. D. Royston, J. H. Levy, J. Fitch, W. Dietrich, S. C. Body, J. M. Murkin, B. D. Spiess, and A. Nadel. Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes. Anesth.Analg. 103 (5):1082-1088, 2006.



25. P. K. Smith, M. Carrier, J. C. Chen, A. Haverich, J. H. Levy, P. Menasche, S. K. Shernan, Werf F. Van de, P. X. Adams, T. G. Todaro, and E. Verrier. Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time. Ann.Thorac.Surg. 82 (3):781-788, 2006.



26. F. Szlam, J. H. Levy, and K. A. Tanaka. Tissue plasminogen activator and thrombin generation measurements using the Thrombinoscope. Blood Coagul.Fibrinolysis 17 (7):603-604, 2006.



27. K. A. Tanaka and R. Sniecinski. Systemic thromboses after cardiopulmonary bypass: is it thrombin or antithrombin? Anesthesiology 105 (2):428-429, 2006.



28. A. Vasilaki, M. Csete, D. Pye, S. Lee, J. Palomero, F. McArdle, Remmen H. Van, A. Richardson, A. McArdle, J. A. Faulkner, and M. J. Jackson. Genetic modification of the manganese superoxide dismutase/glutathione peroxidase 1 pathway influences intracellular ROS generation in quiescent, but not contracting, skeletal muscle cells. Free Radic.Biol.Med. 41 (11):1719-1725, 2006.



29. D. W. Wright, A. L. Kellermann, V. S. Hertzberg, P. L. Clark, M. Frankel, F. C. Goldstein, J. P. Salomone, L. L. Dent, O. A. Harris, D. S. Ander, D. W. Lowery, M. M. Patel, D. D. Denson, A. B. Gordon, M. M. Wald, S. Gupta, S. W. Hoffman, and D. G. Stein. ProTECT: A Randomized Clinical Trial of Progesterone for Acute Traumatic Brain Injury. Ann.Emerg.Med., 2006.



30. J. M. Hansen, M. Klass, C. Harris, and M. Csete. A reducing redox environment promotes C2C12 myogenesis: Implications for regeneration in aged muscle. Cell Biol.Int., 2006.



31. K. E. Glas. Training in perioperative echocardiography. Curr.Opin.Anaesthesiol. 19 (6):640-644, 2006.



32. J. P. Mathew, K. Glas, C. A. Troianos, P. Sears-Rogan, R. Savage, J. Shanewise, J. Kisslo, S. Aronson, and S. Shernan. American Society of Echocardiography/Society of Cardiovascular Anesthesiologists recommendations and guidelines for continuous quality improvement in perioperative echocardiography. J.Am.Soc.Echocardiogr. 19 (11):1303-1313, 2006.



33. J. P. Mathew, K. Glas, C. A. Troianos, P. Sears-Rogan, R. Savage, J. Shanewise, J. Kisslo, S. Aronson, and S. Shernan. ASE/SCA recommendations and guidelines for continuous quality improvement in perioperative echocardiography. Anesth.Analg. 103 (6):1416-1425, 2006

2005

1. M. G. Byas-Smith, S. L. Chapman, B. Reed, and G. Cotsonis. The effect of opioids on driving and psychomotor performance in patients with chronic pain. Clin. J. Pain 21 (4):345-352, 2005.



2. M. Csete. Oxygen in the cultivation of stem cells. Ann. N.Y. Acad. Sci. 1049:1-8, 2005.



3. D. D. Denson, J. Li, X. Wang, and D. C. Eaton. Activation of BK channels in GH3 cells by a c-PLA2-dependent G-protein signaling pathway. J. Neurophysiol. 93 (6):3146-3156, 2005.



4. N. Katori, K. A. Tanaka, F. Szlam, and J. H. Levy. The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastography. Anesth. Analg. 100 (6):1781-1785, 2005.



5. C. Kerssens, S. Hamann, S. Peltier, X. P. Hu, M. G. Byas-Smith, and P. S. Sebel. Attenuated Brain Response to Auditory Word Stimulation with Sevoflurane: A Functional Magnetic Resonance Imaging Study in Humans. Anesthesiology 103 (1):11-19, 2005.



6. C. Kerssens, T. Ouchi, and P. S. Sebel. No evidence of memory function during anesthesia with propofol or isoflurane with close control of hypnotic state. Anesthesiology 102 (1):57-62, 2005.



7. M. Kodaka, J. W. Johansen, and P. S. Sebel. The influence of gender on loss of consciousness with sevoflurane or propofol. Anesth. Analg. 101 (2):377-381, 2005.



8. A. Losken, H. Seify, D. D. Denson, A. A. Paredes, Jr., and G. W. Carlson. Validating three-dimensional imaging of the breast. Ann. Plast. Surg. 54 (5):471-476, 2005.



9. J. Ramsay, S. Shernan, J. Fitch, P. Finnegan, T. Todaro, T. Filloon, and N. A. Nussmeier. Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves. J.T horac. Cardiovasc. Surg. 129 (2):300-306, 2005.



10. K. A. Tanaka, N. Katori, A. B. Kelly, H. Kotze, U. Marzec, and S. R. Hanson. In vivo platelet redistribution and acute transient thrombocytopenia after eptifibatide injection in baboons. Thromb. Res. 115 (1-2):79-87, 2005.



11. D. W. Wright, J. C. Ritchie, R. E. Mullins, A. L. Kellermann, and D. D. Denson. Steady-state serum concentrations of progesterone following continuous intravenous infusion in patients with acute moderate to severe traumatic brain injury. J. Clin. Pharmacol. 45 (6):640-648, 2005.



12. ASA Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices, James R. Zaidan, MD, MBA, Chair. Practice Advisory for the Periperative Management of Patients with Cardiac Rhythm Managemsnt Devices: Pacemakers and Implantable Cardioverter-Defibrillators. Anesthesiology 2005; 103: 186-198.



13. M. S. Avidan, J. H. Levy, J. Scholz, E. Delphin, P. M. Rosseel, M. B. Howie, I. Gratz, C. R. Bush, N. Skubas, G. S. Aldea, M. Licina, L. J. Bonfiglio, D. K. Kajdasz, E. Ott, and G. J. Despotis. A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass. Anesthesiology 102 (2):276-284, 2005.



14. M. S. Avidan, J. H. Levy, Aken H. van, R. O. Feneck, R. D. Latimer, E. Ott, E. Martin, D. E. Birnbaum, L. J. Bonfiglio, D. K. Kajdasz, and G. J. Despotis. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 130 (1):107-113, 2005.



15. J. Doyle and M. Csete. Motifs, control, and stability. PLoS. Biol. 3 (11):e392, 2005.



16. C. M. Dyke, A. Koster, J. J. Veale, G. W. Maier, T. McNiff, and J. H. Levy. Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia. Ann. Thorac. Surg. 80 (1):299-303, 2005.



17. B. Govindarajan, D. J. Brat, M. Csete, W. D. Martin, E. Murad, K. Litani, C. Cohen, F. Cerimele, M. Nunnelley, B. Lefkove, T. Yamamoto, C. Lee, and J. L. Arbiser. Transgenic expression of dominant negative tuberin through a strong constitutive promoter results in a tissue-specific tuberous sclerosis phenotype in the skin and brain. J. Biol. Chem. 280 (7):5870-5874, 2005.



18. M. E. Halkos, J. H. Levy, E. Chen, V. S. Reddy, O. M. Lattouf, R. A. Guyton, and H. K. Song. Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery. Ann. Thorac. Surg. 79 (4):1303-1306, 2005.



19. M. Klass, A. Hord, M. Wilcox, D. Denson, and M. Csete. A role for endothelin in neuropathic pain after chronic constriction injury of the sciatic nerve. Anesth. Analg. 101 (6):1757-1762, 2005.



20. J. H. Levy. Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation. Am. J. Health Syst. Pharm. 62 (18 Suppl 4):S15-S19, 2005.



21. J. H. Levy, K. A. Tanaka, and M. E. Steiner. Evaluation and management of bleeding during cardiac surgery. Curr. Hematol. Rep. 4 (5):368-372, 2005.



22. A. Losken, I. Fishman, D. D. Denson, H. R. Moyer, and G. W. Carlson. An Objective Evaluation of Breast Symmetry and Shape Differences Using 3-Dimensional Images. Ann. Plast. Surg. 55 (6):571-575, 2005.



23. S. J. Peltier, C. Kerssens, S. B. Hamann, P. S. Sebel, M. Byas-Smith, and X. Hu. Functional connectivity changes with concentration of sevoflurane anesthesia. Neuroreport 16 (3):285-288, 2005.



24. H. A. Sampson, A. Munoz-Furlong, S. A. Bock, C. Schmitt, R. Bass, B. A. Chowdhury, W. W. Decker, T. J. Furlong, S. J. Galli, D. B. Golden, R. S. Gruchalla, A. D. Harlor, Jr., D. L. Hepner, M. Howarth, A. P. Kaplan, J. H. Levy, L. M. Lewis, P. L. Lieberman, D. D. Metcalfe, R. Murphy, S. M. Pollart, R. S. Pumphrey, L. J. Rosenwasser, F. E. Simons, J. P. Wood, and C. A. Camargo, Jr. Symposium on the definition and management of anaphylaxis: summary report. J. Allergy Clin. Immunol. 115 (3):584-591, 2005.



25. H. Sun, R. P. Apkarian, S. N. Dublin, J. H. Levy, and K. A. Tanaka. Scanning electron microscopical observations of two novel hemostatic polymers. J. Thromb. Haemost. 3 (7):1537-1539, 2005.



26. K. A. Tanaka, F. Szlam, J. Vinten-Johansen, A. D. Cardin, and J. H. Levy. Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan. Thromb. Haemost. 94 (4):808-813, 2005.



27. X. Zhu, K. L. Mills, P. R. Peters, J. H. Bahng, E. H. Liu, J. Shim, K. Naruse, M. E. Csete, M. D. Thouless, and S. Takayama. Fabrication of reconfigurable protein matrices by cracking. Nat. Mater. 4 (5):403-406, 2005.



28. N. A. Guzzetta, B. E. Miller, K. Todd, F. Szlam, R. H. Moore, and S. R. Tosone. An evaluation of the effects of a standard heparin dose on thrombin inhibition during cardiopulmonary bypass in neonates. Anesth.Analg. 100 (5):1276-82, 2005.



29. Homanics GE, Elsen FP, Ying SW, Jenkins A, Ferguson C, Sloat B, Yuditskaya S, Goldstein PA, Kralic JE, Morrow AL, Harrison NL. A gain-of-function mutation in the GABA receptor produces synaptic and behavioral abnormalities in the mouse. Genes Brain Behav. 2005 Feb;4(1):10-9.

2004

1. M. G. Byas-Smith, J. Li, F. Szlam, D. C. Eaton, J. R. Votaw, and D. D. Denson. Isoflurane induces dopamine transporter trafficking into the cell cytoplasm. Synapse 53 (2):68-73, 2004.



2. M. Csete, L. Rodriguez, M. Wilcox, and S. Chadalavada. Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts. Neurosci.Lett. 359 (1-2):124-126, 2004.



3. M. Kikura, J. H. Levy, R. A. Safon, M. K. Lee, and F. Szlam. The influence of red wine or white wine intake on platelet function and viscoelastic property of blood in volunteers. Platelets. 15 (1):37-41, 2004.



4. J. H. Levy. Heparin resistance and antithrombin: should it still be called heparin resistance? J.Cardiothorac.Vasc.Anesth. 18 (2):129-130, 2004.



5. J. H. Levy. Anaphylactic reactions to neuromuscular blocking drugs: are we making the correct diagnosis? Anesth.Analg. 98 (4):881-882, 2004.



6. T. Quach, M. Tippens, F. Szlam, R. Van Dyke, J. H. Levy, and M. Csete. Quantitative assessment of fibrinogen cross-linking by epsilon aminocaproic acid in patients with end-stage liver disease. Liver Transpl. 10 (1):123-128, 2004.



7. P. S. Sebel. Comfortably numb? Acta Anaesthesiol.Scand. 48 (1):1-3, 2004.



8. K. A. Tanaka, F. Szlam, N. Katori, A. Tsuda, and J. H. Levy. In vitro effects of antihypertensive drugs on thromboxane agonist (U46619)-induced vasoconstriction in human internal mammary artery. Br.J.Anaesth., 2004.



9. E. D. Verrier, S. K. Shernan, K. M. Taylor, Werf F. Van de, M. F. Newman, J. C. Chen, M. Carrier, A. Haverich, K. J. Malloy, P. X. Adams, T. G. Todaro, C. F. Mojcik, S. A. Rollins, and J. H. Levy. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA 291 (19):2319-2327, 2004.



10. M. Csete and J. Doyle. Bow ties, metabolism and disease. Trends Biotechnol. 22 (9):446-450, 2004.



11. K. E. Glas, J. S. Shanewise, and R. A. Guyton. An unusual cause of left ventricular outflow tract obstruction after mitral valve repair. Anesth.Analg. 99 (1):38-40, 2004.



12. J. H. Levy and E. Sypniewski. Aprotinin: a pharmacologic overview. Orthopedics 27 (6 Suppl):s653-s658, 2004.



13. J. H. Levy. Safety of aprotinin in heparinized and nonheparinized patients. J. Cardiothorac. Vasc. Anesth. 18 (4 Suppl):S38-S42, 2004.



14. J. H. Levy. Efficacy and safety of aprotinin in cardiac surgery. Orthopedics 27 (6 Suppl):s659-s662, 2004.



15. J. Ramsay. Con: cardiothoracic anesthesiologists should not run postcardiac surgical intensive care units. J.Cardiothorac.Vasc.Anesth. 18 (4):525-526, 2004.



16. P. S. Sebel, T. A. Bowdle, M. M. Ghoneim, I. J. Rampil, R. E. Padilla, T. J. Gan, and K. B. Domino. The incidence of awareness during anesthesia: a multicenter United States study. Anesth.Analg. 99 (3):833-9, table, 2004.



17. K. A. Tanaka, F. Szlam, A. B. Kelly, J. D. Vega, and J. H. Levy. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding. Platelets. 15 (5):325-332, 2004.



18. K. A. Tanaka, F. Szlam, N. Katori, N. Sato, J. D. Vega, and J. H. Levy. The effects of argatroban on thrombin generation and hemostatic activation in vitro. Anesth.Analg. 99 (5):1283-1289, 2004.



19. K. A. Tanaka, N. Katori, F. Szlam, N. Sato, A. B. Kelly, and J. H. Levy. Effects of tirofiban on haemostatic activation in vitro. Br.J.Anaesth. 93 (2):263-269, 2004.



20. K. A. Tanaka, F. Szlam, N. Katori, J. D. Vega, and J. H. Levy. Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro. Thromb. Res. 113 (5):333-339, 2004.



21. Adam, N., Sebel, P.S. BIS Monitoring: Awareness and catastrophic events. Semin Cardiothorac Vasc Anesth 8: T1-T4, 2004.

2003

1. C. F. Bannister, K. K. Brosius, and M. Wulkan. The effect of insufflation pressure on pulmonary mechanics in infants during laparoscopic surgical procedures. Paediatr.Anaesth. 13 (9):785-789, 2003.



2. K. K. Brosius and C. F. Bannister. Midazolam premedication in children: a comparison of two oral dosage formulations on sedation score and plasma midazolam levels. Anesth.Analg. 96 (2):392-5, 2003.



3. M. Byas-Smith, J. Votaw, J. Hua, R. Voll, L. Martarello, A. I. Levey, and M. Goodman. Phenylephrine and norepinephrine increase dopamine transporter ligand binding in striatum. Mol.Imaging Biol. 5 (4):217-226, 2003.



4. M. R. Davis, J. R. Votaw, J. D. Bremner, M. G. Byas-Smith, T. L. Faber, R. J. Voll, J. M. Hoffman, S. T. Grafton, C. D. Kilts, and M. M. Goodman. Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT. J.Nucl.Med. 44 (6):855-861, 2003.



5. J. Votaw, M. Byas-Smith, J. Hua, R. Voll, L. Martarello, A. I. Levey, F. D. Bowman, and M. Goodman. Interaction of isoflurane with the dopamine transporter. Anesthesiology 98 (2):404-411, 2003.



6. B. E. Miller, N. A. Guzzetta, S. R. Tosone, J. L. Miller, A. R. Flunker, E. M. Silvey, and J. H. Levy. Tissue factor-activated thromboelastograms in children undergoing cardiac surgery: baseline values and comparisons. Anesth.Analg. 97 (5):1289-1293, 2003.



7. J. D. Puskas, W. H. Williams, P. G. Duke, J. R. Staples, K. E. Glas, J. J. Marshall, M. Leimbach, P. Huber, S. Garas, B. H. Sammons, S. A. McCall, R. J. Petersen, D. E. Bailey, H. Chu, E. M. Mahoney, W. S. Weintraub, and R. A. Guyton. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J.Thorac.Cardiovasc.Surg. 125 (4):797-808, 2003.



8. J. H. Levy. Novel pharmacologic approaches to reduce bleeding. Can.J.Anaesth. 50 (6 Suppl):S26-S30, 2003.



9. B. E. Miller, N. A. Guzzetta, S. R. Tosone, J. L. Miller, A. R. Flunker, E. M. Silvey, and J. H. Levy. Tissue factor-activated thromboelastograms in children undergoing cardiac surgery: baseline values and comparisons. Anesth.Analg. 97 (5):1289-1293, 2003.



10. K. A. Tanaka, J. D. Vega, A. B. Kelly, S. R. Hanson, and J. H. Levy. Eptifibatide-induced thrombocytopenia and coronary bypass operation. J.Thromb.Haemost. 1 (2):392-394, 2003.



11. J. H. Levy. The use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss. Expert.Opin.Biol.Ther. 3 (3):509-517, 2003.



12. K. A. Tanaka, A. A. Waly, W. A. Cooper, and J. H. Levy. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). Anesthesiology 98 (6):1513-1515, 2003.



13. L. T. Robertson, J. H. Levy, D. Petrisor, D. J. Lilly, and W. K. Dong. Vibration perception thresholds of human maxillary and mandibular central incisors. Arch.Oral Biol. 48 (4):309-316, 2003.



14. J. H. Levy and K. A. Tanaka. Inflammatory response to cardiopulmonary bypass. Ann.Thorac.Surg. 75 (2):S715-S720, 2003.



15. N. Sato, K. A. Tanaka, F. Szlam, A. Tsuda, M. E. Arias, and J. H. Levy. The vasodilatory effects of hydralazine, nicardipine, nitroglycerin, and fenoldopam in the human umbilical artery. Anesth.Analg. 96 (2):539-44, 2003.



16. C. Kerssens, J. Klein, and B. Bonke. Awareness: Monitoring versus remembering what happened. Anesthesiology 99 (3):570-575, 2003.



17. W. Lu, J. G. Ramsay, and J. M. Bailey. Reliability of pharmacodynamic analysis by logistic regression: mixed-effects modeling. Anesthesiology 99 (6):1255-1262, 2003.



18. J. S. Shanewise and J. G. Ramsay. Off-pump coronary surgery: how do the anesthetic considerations differ? Anesthesiol.Clin.North America. 21 (3):613-23, 2003.



19. A. H. Hord, D. D. Denson, A. G. Chalfoun, and M. I. Azevedo. The effect of systemic zonisamide (Zonegran) on thermal hyperalgesia and mechanical allodynia in rats with an experimental mononeuropathy. Anesth.Analg. 96 (6):1700-6, 2003.



20. B. Ginsberg, R. S. Sinatra, L. J. Adler, J. C. Crews, A. H. Hord, C. E. Laurito, and M. A. Ashburn. Conversion to oral controlled-release oxycodone from intravenous opioid analgesic in the postoperative setting. Pain Med. 4 (1):31-38, 2003.



21. G. Schneider, C. Elidrissi, and P. S. Sebel. Bispectral index-guided administration of anaesthesia: comparison between remifentanil/propofol and remifentanil/isoflurane. Eur.J.Anaesthesiol. 20 (8):624-630, 2003.



22. Howie MB, Michelsen LG, Hug CC Jr, Porembka DT, Jopling MW, Warren S, Shaika S: Comparison of three remifentanil dose-finding regimens for coronary artery surgery. J Cardiothoracic Vascular Anesthesia 2003; 17: 51-59.

2002

1. K. K. Brosius and C. F. Bannister. Oral midazolam premedication in preadolescents and adolescents. Anesth.Analg. 94 (1):31-6, 2002.



2. M. Byas-Smith, M. A. Frolich, J. R. Votaw, T. L. Faber, and J. M. Hoffman. Cerebral blood flow during propofol induced sedation. Mol.Imaging Biol. 4 (2):139-146, 2002.



3. S. L. Chapman, M. G. Byas-Smith, and B. A. Reed. Effects of intermediate- and long-term use of opioids on cognition in patients with chronic pain. Clin.J.Pain 18 (4 Suppl):S83-S90, 2002.



4. T. Koitabashi, J. W. Johansen, and P. S. Sebel. Remifentanil dose/electroencephalogram bispectral response during combined propofol/regional anesthesia. Anesth.Analg. 94 (6):1530-3, 2002.



5. S. Ruesch and J. H. Levy. Treatment of persistent tachycardia with dexmedetomidine during off-pump cardiac surgery. Anesth.Analg. 95 (2):316-8, 2002.



6. J. H. Levy, L. T. Goodnough, P. E. Greilich, G. V. Parr, R. W. Stewart, I. Gratz, J. Wahr, J. Williams, M. E. Comunale, D. Doblar, G. Silvay, M. Cohen, J. S. Jahr, and G. J. Vlahakes. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J.Thorac.Cardiovasc.Surg. 124 (1):35-42, 2002.



7. A. Koster, G. Despotis, M. Gruendel, T. Fischer, M. Praus, H. Kuppe, and J. H. Levy. The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation. Anesth.Analg. 95 (1):26-30, 2002.



8. J. H. Levy, G. J. Despotis, F. Szlam, P. Olson, D. Meeker, and A. Weisinger. Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study. Anesthesiology 96 (5):1095-1102, 2002.



9. J. M. Bailey, W. Lu, J. H. Levy, J. G. Ramsay, L. Shore-Lesserson, R. C. Prielipp, N. W. Brister, G. W. Roach, A. Jolin-Mellgard, and M. Nordlander. Clevidipine in adult cardiac surgical patients: a dose-finding study. Anesthesiology 96 (5):1086-1094, 2002.



10. J. Sprung, J. D. Kindscher, J. A. Wahr, J. H. Levy, T. G. Monk, M. W. Moritz, and P. J. O'Hara. The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial. Anesth.Analg. 94 (4):799-808, 2002.



11. J. H. Levy, J. M. Bailey, and G. M. Deeb. Intravenous milrinone in cardiac surgery. Ann.Thorac.Surg. 73 (1):325-330, 2002.



12. B. E. Miller and K. K. Spitzer. Anesthetic and perfusion issues in contemporary pediatric cardiac surgery. Crit Care Nurs.Q. 25 (3):48-62, 2002.



13. J. M. Bailey. Context-sensitive half-times: what are they and how valuable are they in anaesthesiology? Clin.Pharmacokinet. 41 (11):793-799, 2002.



14. J. Ramsay. How much cardiac output is enough? J.Cardiothorac.Vasc.Anesth. 16 (1):1-3, 2002.



15. S. Aronson, A. Butler, R. Subhiyah, R. E. Buckingham, Jr., M. K. Cahalan, S. Konstandt, J. Mark, J. Ramsay, R. Savage, J. Savino, J. S. Shanewise, J. Smith, and D. Thys. Development and analysis of a new certifying examination in perioperative transesophageal echocardiography. Anesth.Analg. 95 (6):1476-82, 2002.



16. Kerssens C, Lubke GH, Klein J, van der Woerd A, Bonke B. Memory function during propofol/alfentanil anesthesia: Predictive value of individual differences. Anesthesiology 97: 382-389, 2002.